SUBMIT YOUR RESEARCH
Saudi Journal of Medical and Pharmaceutical Sciences (SJMPS)
Volume-7 | Issue-11 | 571-574
Review Article
Tuberculosis (TB) Silent Killer, Challenges and Stategies to Manage Tuberculosis during COVID -19 Pandemic: A Review
Ajaz Ahmed Wani, Rahul Kait
Published : Nov. 9, 2021
DOI : 10.36348/sjmps.2021.v07i11.005
Abstract
Tuberculosis (TB) is an infectious diseases caused by an intracellular pathogen called Mycobacterium tuberculi. It is a disease prevalent worldwide for its vulnerability, magnitude and morbidity factors. With the advancement in the field of medical science, it is still a serious global public health problem and it is in the top 10 causes of mortality particularly in the underdeveloped countries. Besides the other deadly diseases, TB remains on the horizon of public health, mainly due to its persistence and high rates in communities living in poverty and on the margins of social exclusions. While assessing the challenges due to covid -19 pandemic, simultaneously management of tuberculosis and current strategies adopted to mitigate them.
Scholars Middle East Publishers
Browse Journals
Payments
Publication Ethics
SUBMIT ARTICLE
Browse Journals
Payments
Publication Ethics
SUBMIT ARTICLE
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
© Copyright Scholars Middle East Publisher. All Rights Reserved.